Short answer
COLLEGIUM PHARMACEUTICAL, INC (COLL) filed an 8-K current report with the SEC on August 13, 2026 reporting Item 8.01 (Other Events). $50 million ASR with Jefferies, representing part of the $150 million repurchase program authorized in July 2025.
COLLEGIUM PHARMACEUTICAL, INC 8-K event analysis
AI summary of each reported item and its exhibits
Item 8.01 · Other Events
- $50 million ASR with Jefferies, representing part of the $150 million repurchase program authorized in July 2025
- Initial delivery of 1,556,420 shares, approximately 80% of expected ASR shares
- Initial shares valued using $25.70 closing price on August 12, 2026
- Final share count tied to volume-weighted average price, with settlement expected by fourth quarter 2026
- Repurchase reduces shares outstanding from approximately 32.5 million, potentially increasing per-share ownership and earnings metrics
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other COLLEGIUM PHARMACEUTICAL, INC 8-K filings
Get the next COLL 8-K as it lands
Follow COLL for push alerts, or ask the research agent what this filing means.